Get the Stockscreener App
289.33
0.10%
-0.30
After Hours:
289.33
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $289.33, with a volume of 6.80M.
It is down -0.10% in the last 24 hours and up +5.21% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$289.63
Open:
$292.17
24h Volume:
6.80M
Relative Volume:
2.34
Market Cap:
$157.78B
Revenue:
$34.13B
Net Income/Loss:
$5.93B
P/E Ratio:
26.40
EPS:
10.96
Net Cash Flow:
$10.92B
1W Performance:
-2.00%
1M Performance:
+5.21%
6M Performance:
+9.85%
1Y Performance:
-6.63%
1-Day Range:
$288.54
$294.55
1-Week Range:
$286.60
$298.77
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
289.33 | 157.78B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
762.73 | 724.64B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
149.79 | 376.43B | 89.33B | 21.81B | 18.57B | 8.99 |
|
NVO
Novo Nordisk Adr
|
73.77 | 352.49B | 43.59B | 15.04B | 10.74B | 3.3766 |
|
ABBV
Abbvie Inc
|
185.30 | 334.73B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
115.77 | 234.21B | 53.22B | 12.86B | 14.85B | 6.39 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Trust Point Inc. Has $411,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sagespring Wealth Partners LLC Sells 2,343 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) to Present Key Study Findings at Diabetes Conference - GuruFocus
Amgen to present data from mid-stage obesity study (AMGN:NASDAQ) - Seeking Alpha
Amgen (AMGN) to Present Key Study Results at Diabetes Conference - GuruFocus
AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS | AMGN Stock News - GuruFocus
Revolutionary Monthly Obesity Treatment MariTide Achieves Continuous Weight Loss at 52 Weeks - Stock Titan
CWA Asset Management Group LLC Has $7.16 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Clarius Group LLC Has $3.20 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Mn Services Vermogensbeheer B.V. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by New Century Financial Group LLC - MarketBeat
Amgen Boosts Growth With Strong Q1 Results and $1.9B Infrastructure Investment - MSN
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks - The Motley Fool
Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 47% gain - Yahoo Finance
8,490 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Lesa Sroufe & Co - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Reduced by PKO Investment Management Joint Stock Co - MarketBeat
CENTRAL TRUST Co Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Chicago Capital LLC Sells 1,212 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Consilium Wealth Advisory LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AA Financial Advisors LLC Takes $524,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sowell Financial Services LLC Sells 1,054 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Elevation Point Wealth Partners LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Saudi Arabia Signs Multiple Healthcare Deals, Partnerships at BIO 2025 - MarketScreener
Amgen’s Strong Cash Flow Supports Reliable Dividend Payments - MSN
New England Research & Management Inc. Sells 2,926 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Renews Push for Colorado Payment Cap Halt At Appeals Court - Bloomberg Law News
Amgen Inc. (NASDAQ:AMGN) Stock Position Increased by Precedent Wealth Partners LLC - MarketBeat
QRG Capital Management Inc. Buys 4,945 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Janney Montgomery Scott LLC Acquires 35,100 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Cyndeo Wealth Partners LLC - MarketBeat
EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Fort Washington Investment Advisors Inc. OH - MarketBeat
Hanson & Doremus Investment Management Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argus Investors Counsel Inc. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Birch Capital Management LLC Has $7.41 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NorthCrest Asset Manangement LLC Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by North Star Investment Management Corp. - MarketBeat
Brighton Jones LLC Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ritholtz Wealth Management Has $4.08 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Foster Victor Wealth Advisors LLC Has $13.78 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH - MarketBeat
Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial - MSN
Dynamic Advisor Solutions LLC Purchases 1,591 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Trimmed by Greenwood Capital Associates LLC - MarketBeat
CX Institutional Sells 3,410 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s SWOT analysis: stock outlook amid obesity drug race - Investing.com
Franklin Street Advisors Inc. NC Sells 21,974 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
2,918 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Davis Investment Partners LLC - MarketBeat
Ferguson Wellman Capital Management Inc. Purchases 170,577 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen: Imdelltra Data And Q1 Results Impress - Seeking Alpha
Amgen (AMGN) Stock Rally Hits Wall of Resistance in Volatile Trading Session - Daily Chhattisgarh News
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.38%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):